Literature DB >> 32032752

MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.

Giovanni Battista Migliori1, Simon Tiberi2, Alimuddin Zumla3, Eskild Petersen4, Jeremiah Muhwa Chakaya5, Christian Wejse6, Marcela Muñoz Torrico7, Raquel Duarte8, Jan Willem Alffenaar9, H Simon Schaaf10, Ben J Marais11, Daniela Maria Cirillo12, Riccardo Alagna13, Adrian Rendon14, Emanuele Pontali15, Alberto Piubello16, José Figueroa17, Gabriella Ferlazzo18, Alberto García-Basteiro19, Rosella Centis20, Dina Visca21, Lia D'Ambrosio22, Giovanni Sotgiu23.   

Abstract

The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention and rehabilitation requires frequent update of existing guidelines. This review is aimed at providing clinicians and public health staff with an updated and easy-to-consult document arising from consensus of Global Tuberculosis Network (GTN) experts. The core published documents and guidelines have been reviewed, including the recently published MDR-TB WHO rapid advice and ATS/CDC/ERS/IDSA guidelines. After a rapid review of epidemiology and risk factors, the clinical priorities on MDR-TB diagnosis (including whole genome sequencing and drug-susceptibility testing interpretations) and treatment (treatment design and management, TB in children) are discussed. Furthermore, the review comprehensively describes the latest information on contact tracing and LTBI management in MDR-TB contacts, while providing guidance on post-treatment functional evaluation and rehabilitation of TB sequelae, infection control and other public health priorities.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Diagnosis; MDR-TB; Prevention; Rehabilitation of sequelae; Treatment; XDR-TB

Mesh:

Year:  2020        PMID: 32032752     DOI: 10.1016/j.ijid.2020.01.042

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  29 in total

1.  Application of KTH-integrated nursing model in care of patients with multi-drug resistant tuberculosis.

Authors:  Hanfen Wei; Xiaoqian Duan
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Effect of targeted nursing intervention plus psychological counseling on quality of life, negative emotions, and complications in patients with extensively drug-resistant tuberculosis.

Authors:  Yanhua Lu; Hongqian Wang; Jianfeng Zhu; Na Wang; Dan Cui; Lingdi Li
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

3.  Factors contributing to the high prevalence of multidrug-resistance/Rifampicin-resistance in patients with tuberculosis: an epidemiological cross sectional and qualitative study from Khabarovsk krai region of Russia.

Authors:  Ilia Bykov; Olga Dyachenko; Pavel Ratmanov; Huan Liu; Libo Liang; Qunhong Wu
Journal:  BMC Infect Dis       Date:  2022-07-13       Impact factor: 3.667

4.  Treatment outcomes and associated factors among patients with multidrug-resistant tuberculosis in Ashanti Region, Ghana: a retrospective, cross-sectional study.

Authors:  Victoria Panford; Emmanuel Kumah; Collins Kokuro; Prince Owusu Adoma; Michael Afari Baidoo; Adam Fusheini; Samuel Egyakwa Ankomah; Samuel Kofi Agyei; Peter Agyei-Baffour
Journal:  BMJ Open       Date:  2022-07-05       Impact factor: 3.006

5.  Clinical standards for the assessment, management and rehabilitation of post-TB lung disease.

Authors:  G B Migliori; F M Marx; N Ambrosino; E Zampogna; H S Schaaf; M M van der Zalm; B Allwood; A L Byrne; K Mortimer; R S Wallis; G J Fox; C C Leung; J M Chakaya; B Seaworth; A Rachow; B J Marais; J Furin; O W Akkerman; F Al Yaquobi; A F S Amaral; S Borisov; J A Caminero; A C C Carvalho; D Chesov; L R Codecasa; R C Teixeira; M P Dalcolmo; S Datta; A-T Dinh-Xuan; R Duarte; C A Evans; J-M García-García; G Günther; G Hoddinott; S Huddart; O Ivanova; R Laniado-Laborín; S Manga; K Manika; A Mariandyshev; F C Q Mello; S G Mpagama; M Muñoz-Torrico; P Nahid; C W M Ong; D J Palmero; A Piubello; E Pontali; D R Silva; R Singla; A Spanevello; S Tiberi; Z F Udwadia; M Vitacca; R Centis; L D Ambrosio; G Sotgiu; C Lange; D Visca
Journal:  Int J Tuberc Lung Dis       Date:  2021-10-01       Impact factor: 3.427

6.  Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities.

Authors:  Pengxu Wang; Sarah M Batt; Bin Wang; Lei Fu; Rongfei Qin; Yu Lu; Gang Li; Gurdyal S Besra; Haihong Huang
Journal:  J Med Chem       Date:  2021-04-14       Impact factor: 7.446

7.  Drug-Resistant Tuberculosis Presenting as a Testicular Mass: A Case Report.

Authors:  Edwin Nuwagira; Mitala Yekosani; Birungi Abraham; Raymond Atwine; Tuhumwire Caleb; Joseph Baruch Baluku
Journal:  Int Med Case Rep J       Date:  2021-03-02

Review 8.  Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?

Authors:  Hazel M Dockrell; Helen McShane
Journal:  EBioMedicine       Date:  2022-04-12       Impact factor: 11.205

9.  Characteristics and Treatment Outcomes of Patients with Tuberculosis Receiving Adjunctive Surgery in Uzbekistan.

Authors:  Anvar Riskiyev; Ana Ciobanu; Arax Hovhannesyan; Kristina Akopyan; Jamshid Gadoev; Nargiza Parpieva
Journal:  Int J Environ Res Public Health       Date:  2021-06-17       Impact factor: 3.390

10.  Structure, In Vivo Detection, and Antibacterial Activity of Metabolites of SQ109, an Anti-Infective Drug Candidate.

Authors:  Satish R Malwal; Matthew D Zimmerman; Nadine Alvarez; Jansy P Sarathy; Véronique Dartois; Carol A Nacy; Eric Oldfield
Journal:  ACS Infect Dis       Date:  2021-07-19       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.